← Eichor
Condition: Streptococcus Pneumoniae Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Streptococcus Pneumoniae

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs
Phase 4 · 1 location(s) · University of Sao Paulo General Hospital · NCT07242092
Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine
Phase 3 · 1 location(s) · Sinovac Life Sciences Co., Ltd. · NCT06617715
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910
Serum Collection Study for Assay Development
Phase 1 · 1 location(s) · GPN Vaccines · NCT07205289
A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infant
Phase 3 · 3 location(s) · CanSino Biologics Inc. · NCT07017777
Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15
Phase 4 · 2 location(s) · University of Oxford · NCT06731374
Immunogenicity and Safety PCV-20 of the Vaccine Administered During an Acute Febrile Illness in Adults
Phase 4 · 24 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT06822907
Nasopharyngeal Carriage of S. Pneumoniae
NA · 1 location(s) · Association Clinique Thérapeutique Infantile du val de Marne · NCT04460313
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
Phase 2 · 1 location(s) · University of California, Davis · NCT02232191
Evaluation of Streptococcus Pneumoniae Serotypes Prevalence Using a Urinary Kit
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT04647630
National Bacterial Meningitis Study in Children and Newborns
Phase N/A · 1 location(s) · Association Clinique Thérapeutique Infantile du val de Marne · NCT04664569
Safety and Efficacy of wSp Vaccine in Young Children
Phase 2 · 7 location(s) · Serum Life Science Europe GmbH · NCT07216430
Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20)
Phase 4 · 7 location(s) · Poitiers University Hospital · NCT04460235
Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines
Phase 4 · 1 location(s) · University of Alabama at Birmingham · NCT07135453
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Phase 1 · 14 location(s) · Merck Sharp & Dohme LLC · NCT07300267
Post Pandemic Pneumococcal Carriage Among Children and Adults
Phase N/A · 1 location(s) · University of Central Florida · NCT06373328
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adoles
Phase 3 · 44 location(s) · Pfizer · NCT07660198
Bacteriological Evaluation of Children With Otorrhea
Phase N/A · 1 location(s) · Association Clinique Thérapeutique Infantile du val de Marne · NCT04807660
Clinical Trial of PCV24 in Infants Aged 2-23 Months
Phase 1 · 2 location(s) · Sinovac Life Sciences Co., Ltd. · NCT06800261
A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market
Phase N/A · 1 location(s) · Pfizer · NCT06760208
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Phase 3 · 97 location(s) · Pfizer · NCT07629440
Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years
Phase 2 · 3 location(s) · Sinovac Life Sciences Co., Ltd. · NCT07300644
Lebanese Interhospital Pneumococcal Surveillance Program
Phase N/A · 1 location(s) · American University of Beirut Medical Center · NCT00901602
National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns
Phase N/A · 1 location(s) · Association Clinique Thérapeutique Infantile du val de Marne · NCT04664556
Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV
Phase 4 · 1 location(s) · Thomas Benfield · NCT04875819
Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemor
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT06181656
A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healt
Phase 3 · 1 location(s) · Aimei Vacin BioPharm (Zhejiang) Co., Ltd. · NCT06044077
Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia
Phase 2 · 1 location(s) · Seema Bhat · NCT05417165
In-depth Analysis of the Immune Responses in the Upper Respiratory Tract in Older Adults Infected or Colonized With Stre
Phase N/A · 1 location(s) · University Hospital, Geneva · NCT06998251
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
Phase 3 · 19 location(s) · Sanofi · NCT07348692
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.